Publications

Found 4 results

Filters: Author is Ghassabeh, Gholamreza Hassanzadeh [Clear All Filters]

2014

Yardehnavi, N., M. Behdani, K. Pooshang Bagheri, A. Mahmoodzadeh, H. Khanahmad, D. Shahbazzadeh, M. Habibi-Anbouhi, G. Hassanzade Ghassabeh, and S. Muyldermans, "A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation.", FASEB J, 2014 Jun 2.

Jovčevska, I., N. Zupanec, N. Kočevar, D. Cesselli, N. Podergajs, C. Limbaeck Stokin, M. P. Myers, S. Muyldermans, G. Hassanzade Ghassabeh, H. Motaln, et al., "TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers.", PLoS One, vol. 9, issue 11, pp. e113688, 2014.

2008

Saerens, D., G. Hassanzade Ghassabeh, and S. Muyldermans, "Antibody technology in proteomics.", Brief Funct Genomic Proteomic, vol. 7, issue 4, pp. 275-82, 2008 Jul.

Saerens, D., G. Hassanzade Ghassabeh, and S. Muyldermans, "Single-domain antibodies as building blocks for novel therapeutics.", Curr Opin Pharmacol, vol. 8, issue 5, pp. 600-8, 2008 Oct.